These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 39083929

  • 21. TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis.
    Liu S, Wu J, Chen P, Mohammed SAD, Zhang J, Liu S.
    Biomed Res Int; 2022; 2022():4949148. PubMed ID: 36017390
    [Abstract] [Full Text] [Related]

  • 22. BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats.
    Lu L, Wu C, Lu BJ, Xie D, Wang Z, Bahaji Azami NL, An YT, Wang HJ, Ye G, Sun MY.
    J Ethnopharmacol; 2020 Mar 01; 249():112301. PubMed ID: 31622746
    [Abstract] [Full Text] [Related]

  • 23. Regulation of SIRT1-TLR2/TLR4 pathway in cell communication from macrophages to hepatic stellate cells contribute to alleviates hepatic fibrosis by Luteoloside.
    Xiu M, Zhao Y, Wang X, Yuan S, Qin B, Sun J, Cui L, Song J.
    Acta Histochem; 2023 Jan 01; 125(1):151989. PubMed ID: 36529079
    [Abstract] [Full Text] [Related]

  • 24. Toll-Like Receptor 4-Independent Carbon Tetrachloride-Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice: Role of Hepatic Stellate Cells.
    Kumar S, Wang J, Shanmukhappa SK, Gandhi CR.
    Am J Pathol; 2017 Jun 01; 187(6):1356-1367. PubMed ID: 28412299
    [Abstract] [Full Text] [Related]

  • 25. [Effect of intrauterine lipopolysaccharide infusion on Toll-like receptor 4 signaling transduction pathway in lungs of perinatal rats].
    Yu X, Xiao CJ, Dai HM, Wang W, Meng J, Zhang XT, Ning Q, Luo XP.
    Zhonghua Er Ke Za Zhi; 2009 Sep 01; 47(9):667-71. PubMed ID: 20021788
    [Abstract] [Full Text] [Related]

  • 26. Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.
    Shirai Y, Yoshiji H, Noguchi R, Kaji K, Aihara Y, Douhara A, Moriya K, Namisaki T, Kawaratani H, Fukui H.
    J Gastroenterol Hepatol; 2013 Apr 01; 28(4):723-30. PubMed ID: 23301938
    [Abstract] [Full Text] [Related]

  • 27. Interferon-β Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model.
    Shimozono R, Nishimura K, Akiyama H, Funamoto S, Izawa A, Sai T, Kunita K, Kainoh M, Suzuki T, Kawada N.
    J Interferon Cytokine Res; 2015 Jun 01; 35(6):464-73. PubMed ID: 25715168
    [Abstract] [Full Text] [Related]

  • 28. Autophagic-CTSB-inflammasome axis modulates hepatic stellate cells activation in arsenic-induced liver fibrosis.
    Tao Y, Qiu T, Yao X, Jiang L, Wang N, Jia X, Wei S, Wang Z, Pei P, Zhang J, Zhu Y, Yang G, Liu X, Liu S, Sun X.
    Chemosphere; 2020 Mar 01; 242():124959. PubMed ID: 31669990
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II.
    Li YS, Ni SY, Meng Y, Shi XL, Zhao XW, Luo HH, Li X.
    PLoS One; 2013 Mar 01; 8(10):e76289. PubMed ID: 24155898
    [Abstract] [Full Text] [Related]

  • 30. Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms.
    Zi SF, Li JH, Liu L, Deng C, Ao X, Chen DD, Wu SZ.
    Int Immunopharmacol; 2019 Nov 01; 76():105898. PubMed ID: 31520992
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways.
    Cao F, Zhang Y, Li W, Shimizu K, Xie H, Zhang C.
    Int Immunopharmacol; 2018 Feb 01; 55():183-192. PubMed ID: 29268190
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. TAK-242 Protects Against Apoptosis in Coronary Microembolization-Induced Myocardial Injury in Rats by Suppressing TLR4/NF-κB Signaling Pathway.
    Wang XT, Lu YX, Sun YH, He WK, Liang JB, Li L.
    Cell Physiol Biochem; 2017 Feb 01; 41(4):1675-1683. PubMed ID: 28359050
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent.
    Dattaroy D, Seth RK, Sarkar S, Kimono D, Albadrani M, Chandrashekaran V, Hasson FA, Singh UP, Fan D, Nagarkatti M, Nagarkatti P, Diehl AM, Chatterjee S.
    Eur J Pharmacol; 2018 Dec 15; 841():33-48. PubMed ID: 30194936
    [Abstract] [Full Text] [Related]

  • 38. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses.
    Guo J, Loke J, Zheng F, Hong F, Yea S, Fukata M, Tarocchi M, Abar OT, Huang H, Sninsky JJ, Friedman SL.
    Hepatology; 2009 Mar 15; 49(3):960-8. PubMed ID: 19085953
    [Abstract] [Full Text] [Related]

  • 39. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S, Yang N, Ni S, Li W, Xu L, Dong P, Lu M.
    Int J Clin Exp Pathol; 2014 Mar 15; 7(10):6626-34. PubMed ID: 25400741
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.